title: Is cognitive functioning impaired in methamphetamine users? A critical review.
abstract: The prevailing view is that recreational methamphetamine use causes a broad range of severe cognitive deficits, despite the fact that concerns have been raised about interpretations drawn from the published literature. This article addresses an important gap in our knowledge by providing a critical review of findings from recent research investigating the impact of recreational methamphetamine use on human cognition. Included in the discussion are findings from studies that have assessed the acute and long-term effects of methamphetamine on several domains of cognition, including visuospatial perception, attention, inhibition, working memory, long-term memory, and learning. In addition, relevant neuroimaging data are reviewed in an effort to better understand neural mechanisms underlying methamphetamine-related effects on cognitive functioning. In general, the data on acute effects show that methamphetamine improves cognitive performance in selected domains, that is, visuospatial perception, attention, and inhibition. Regarding long-term effects on cognitive performance and brain-imaging measures, statistically significant differences between methamphetamine users and control participants have been observed on a minority of measures. More importantly, however, the clinical significance of these findings may be limited because cognitive functioning overwhelmingly falls within the normal range when compared against normative data. In spite of these observations, there seems to be a propensity to interpret any cognitive and/or brain difference(s) as a clinically significant abnormality. The implications of this situation are multiple, with consequences for scientific research, substance-abuse treatment, and public policy.
authors.affiliation: Department of Psychology, Columbia University, New York, NY 10032, USA. clh42@columbia.edu
authors.forename: Carl L
authors.initials: CL
authors.lastname: Hart
authors.forename: Caroline B
authors.initials: CB
authors.lastname: Marvin
authors.forename: Rae
authors.initials: R
authors.lastname: Silver
authors.forename: Edward E
authors.initials: EE
authors.lastname: Smith
mesh_terms: D019969:Amphetamine-Related Disorders / Q000523:psychology*; D001288:Attention / Q000187:drug effects; D003071:Cognition / Q000187:drug effects*; D003072:Cognition Disorders / Q000139:chemically induced*; D006801:Humans; D057567:Memory, Long-Term / Q000187:drug effects; D008694:Methamphetamine / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D008694:Methamphetamine
references.citation: Mol Psychiatry. 2008 Sep;13(9):897-908
references.pmid: 17938635
references.citation: Psychopharmacology (Berl). 2006 Oct;188(2):162-70
references.pmid: 16915378
references.citation: Neuropsychopharmacology. 2005 Jul;30(7):1383-91
references.pmid: 15726115
references.citation: Int J Neuropsychopharmacol. 2006 Apr;9(2):221-8
references.pmid: 15982446
references.citation: Psychopharmacology (Berl). 2010 Feb;208(2):169-77
references.pmid: 19916063
references.citation: Synapse. 2001 Feb;39(2):161-6
references.pmid: 11180503
references.citation: Neuropsychopharmacology. 2000 May;22(5):504-12
references.pmid: 10731625
references.citation: Synapse. 2006 Nov;60(6):465-73
references.pmid: 16897726
references.citation: J Clin Psychol. 1993 Jan;49(1):54-60
references.pmid: 8425935
references.citation: J Neurosci. 2001 Dec 1;21(23):9414-8
references.pmid: 11717374
references.citation: Psychopharmacology (Berl). 2001 Jun;155(4):397-404
references.pmid: 11441429
references.citation: J Neurosci. 1997 Feb 1;17(3):960-74
references.pmid: 8994051
references.citation: J Neuropsychiatry Clin Neurosci. 2003 Spring;15(2):215-20
references.pmid: 12724464
references.citation: Psychopharmacology (Berl). 2002 Dec;164(4):376-84
references.pmid: 12457267
references.citation: Biol Psychiatry. 2009 Jan 15;65(2):122-8
references.pmid: 18814867
references.citation: Psychopharmacology (Berl). 2006 Aug;187(2):154-69
references.pmid: 16761129
references.citation: Biol Psychiatry. 2005 May 1;57(9):967-74
references.pmid: 15860336
references.citation: Biol Psychiatry. 2005 Nov 15;58(10):770-8
references.pmid: 16095568
references.citation: Int J Neuropsychopharmacol. 2007 Dec;10(6):765-75
references.pmid: 17147837
references.citation: Psychopharmacology (Berl). 2009 Apr;203(3):609-16
references.pmid: 19037633
references.citation: Psychopharmacologia. 1965 Apr 7;7(5):379-82
references.pmid: 5837314
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):123-30
references.pmid: 16978753
references.citation: Am J Psychiatry. 2001 Aug;158(8):1206-14
references.pmid: 11481152
references.citation: J Neurochem. 1998 Sep;71(3):1289-97
references.pmid: 9721755
references.citation: Compr Psychiatry. 2008 Jul-Aug;49(4):387-92
references.pmid: 18555060
references.citation: J Neurosci. 2009 Nov 25;29(47):14734-40
references.pmid: 19940168
references.citation: Addiction. 2007 Apr;102 Suppl 1:61-9
references.pmid: 17493054
references.citation: Neurosci Biobehav Rev. 2008;32(2):219-36
references.pmid: 18061261
references.citation: Psychopharmacology (Berl). 1978 Sep 15;59(1):13-9
references.pmid: 100808
references.citation: J Dent Child (Chic). 2007 May-Aug;74(2):85-92
references.pmid: 18477425
references.citation: J Pharmacol Exp Ther. 1991 May;257(2):820-9
references.pmid: 1903445
references.citation: Drug Alcohol Depend. 2008 Jan 11;93(1-2):93-102
references.pmid: 17964741
references.citation: Psychopharmacology (Berl). 2001 Aug;157(1):75-81
references.pmid: 11512046
references.citation: Am J Psychiatry. 2010 Jan;167(1):17-23
references.pmid: 20068123
references.citation: Drug Alcohol Depend. 1980 Feb;5(2):145-50
references.pmid: 7353472
references.citation: Oral Dis. 2009 Jan;15(1):27-37
references.pmid: 18992021
references.citation: Annu Rev Neurosci. 2006;29:565-98
references.pmid: 16776597
references.citation: J Neurosci. 2002 Sep 15;22(18):8002-9
references.pmid: 12223553
references.citation: Br J Clin Psychol. 2009 Sep;48(Pt 3):323-7
references.pmid: 19397848
references.citation: Clin Pharmacol Ther. 1971 Mar-Apr;12(2):245-58
references.pmid: 5554941
references.citation: Am Econ Rev. 2009 Mar 1;99(1):324-349
references.pmid: 20543969
references.citation: Hum Brain Mapp. 2007 May;28(5):383-93
references.pmid: 16944492
references.citation: J Am Dent Assoc. 2005 Oct;136(10):1491
references.pmid: 16255475
references.citation: Neuropsychopharmacology. 2002 Jan;26(1):53-63
references.pmid: 11751032
references.citation: Biol Psychiatry. 2009 Apr 15;65(8):706-9
references.pmid: 19136097
references.citation: Am J Psychiatry. 2004 Feb;161(2):242-8
references.pmid: 14754772
references.citation: Biol Psychiatry. 2008 Jan 15;63(2):184-90
references.pmid: 17707348
references.citation: J Pharmacol Exp Ther. 1991 May;257(2):830-5
references.pmid: 1903446
references.citation: J Neurosci. 2004 Jun 30;24(26):6028-36
references.pmid: 15229250
references.citation: Int Rev Neurobiol. 2009;88:101-19
references.pmid: 19897076
references.citation: J Stud Alcohol Drugs. 2010 May;71(3):335-44
references.pmid: 20409426
references.citation: Psychopharmacology (Berl). 2012 Jan;219(1):109-22
references.pmid: 21713605
references.citation: J Pharmacol Exp Ther. 1979 Feb;208(2):195-202
references.pmid: 216794
references.citation: Psychopharmacology (Berl). 2006 Apr;185(3):327-38
references.pmid: 16518646
references.citation: Addiction. 2012 Apr;107(4):783-91
references.pmid: 22050030
references.citation: Neuropsychopharmacology. 2008 May;33(6):1453-63
references.pmid: 17637607
references.citation: Am J Psychiatry. 2001 Mar;158(3):377-82
references.pmid: 11229977
references.citation: Annu Rev Pharmacol Toxicol. 2007;47:681-98
references.pmid: 17209801
references.citation: Neuropsychol Rev. 2007 Sep;17(3):275-97
references.pmid: 17694436
references.citation: Psychopharmacology (Berl). 2011 Apr;214(3):665-74
references.pmid: 21072503
references.citation: Neuropsychopharmacology. 2003 Oct;28(10):1730-40
references.pmid: 12865898
references.citation: Am J Psychiatry. 2001 Dec;158(12):2015-21
references.pmid: 11729018
references.citation: J Pharmacol Exp Ther. 2009 Mar;328(3):1007-18
references.pmid: 19104030
references.citation: J Neurosci. 2008 Sep 24;28(39):9850-6
references.pmid: 18815269
references.citation: Biol Psychiatry. 2003 Jan 1;53(1):65-74
references.pmid: 12513946
references.citation: Psychopharmacology (Berl). 2008 Mar;197(1):137-44
references.pmid: 18043908
references.citation: Prog Neurobiol. 2005 Apr;75(6):406-33
references.pmid: 15955613
references.citation: J Pharmacol Exp Ther. 2000 Oct;295(1):51-7
references.pmid: 10991960
references.citation: J Am Dent Assoc. 2010 Mar;141(3):307-18
references.pmid: 20194387
references.citation: Neurocrit Care. 2009;10(3):295-305
references.pmid: 19132558
references.citation: Am J Psychiatry. 2001 Mar;158(3):383-9
references.pmid: 11229978
references.citation: Psychopharmacology (Berl). 2008 Dec;201(2):183-93
references.pmid: 18685833
references.citation: Arch Gen Psychiatry. 2004 Jan;61(1):73-84
references.pmid: 14706946
references.citation: J Psychiatr Res. 2009 Sep;43(14):1166-70
references.pmid: 19394959
references.citation: Neuropsychopharmacology. 2008 Jul;33(8):1847-55
references.pmid: 17851535
references.citation: J Neurosci. 1998 Oct 15;18(20):8417-22
references.pmid: 9763484
references.citation: Psychiatry Res. 2002 Jun 15;114(2):65-79
references.pmid: 12036507
references.citation: Am J Addict. 2000 Summer;9(3):222-31
references.pmid: 11000918
references.citation: Psychopharmacology (Berl). 2005 Mar;178(2-3):296-302
references.pmid: 15452681
references.citation: Synapse. 2008 Feb;62(2):91-100
references.pmid: 17992686
references.citation: J Addict Dis. 2002;21(1):35-44
references.pmid: 11831498
references.citation: Neuron. 2009 Apr 30;62(2):218-29
references.pmid: 19409267